Skip to main content
Dechra Pharmaceuticals PLC logo

Dechra Pharmaceuticals PLC — Investor Relations & Filings

Ticker · DPH ISIN · US2434351043 LEI · 213800J4UVB5OWG8VX82 IL Manufacturing
Open in API
Filings indexed 1,018 across all filing types
Latest filing 2016-11-30 Director's Dealing
Country GB United Kingdom
Listing IL DPH

About Dechra Pharmaceuticals PLC

https://www.dechra.com/

Dechra Pharmaceuticals PLC is a global specialist business focused on veterinary pharmaceuticals and related products. The company's expertise encompasses the development, manufacture, marketing, and sale of high-quality veterinary medicines. Its product portfolio includes both novel and differentiated generic pharmaceuticals, with a significant focus on products for companion animals. Dechra provides solutions and support to veterinary professionals worldwide to improve animal health and welfare.

Recent filings

Filing Released Lang Actions
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document explicitly mentions 'RNS Number : 5922Q' and details transactions by 'persons discharging managerial responsibilities (PDMRs)' involving the sale of shares by directors (Ian Page and Tony Griffin). This content directly corresponds to insider trading reports or director's dealings, which are typically filed as regulatory disclosures. The definition for Director's Dealing (DIRS) covers 'Report of personal share transactions by company directors and executives (insider trades)'. Although the document is distributed via RNS, the specific content is a Director's Dealing notification, making DIRS the most precise classification. The document structure, including the notification forms and reference to the EU Market Abuse Regulation, confirms this is a specific regulatory filing about insider transactions.
2016-11-30 English
Total Voting Rights
Regulatory Filings Classification · 98% confidence The document is identified by the 'RNS Number : 4483Q' and explicitly states, 'The Company notifies the market of the following:'. The content details the total number of ordinary shares with voting rights (93,038,928) as of the announcement date, which is a mandatory disclosure under DTR 5.6.1R (Disclosure and Transparency Rules). This type of market notification, which is not a full financial report (like 10-K or IR) but a specific regulatory update regarding share capital structure and voting rights denominator, fits best under the general 'Regulatory Filings' category (RNS) as it is a direct announcement to the market via the RNS service, although it relates to share capital. However, since the content is specifically about the total voting rights calculation denominator, it is a very specific regulatory disclosure. Given the options, RNS is the most appropriate general regulatory filing category for this type of market notice that isn't covered by DIRS, DIV, or SHA (which usually implies issuance/repurchase). Since it is a direct notification via RNS about share capital structure for voting purposes, RNS is the correct classification for a general regulatory announcement.
2016-11-30 English
Exercise of LTIP options
Director's Dealing Classification · 100% confidence The document is explicitly labeled with an 'RNS Number' and contains detailed 'Notification of Dealing Forms' regarding transactions by Persons Discharging Managerial Responsibilities (PDMRs) concerning the exercise of stock options. This type of filing, which reports insider transactions (Director's Dealing), is a specific regulatory disclosure. While it is a regulatory announcement, the category 'Directors' Dealing' (DIRS) is more specific than the general 'Regulatory Filings' (RNS). The content directly matches the description for Director's Dealing: 'Report of personal share transactions by company directors and executives (insider trades)'.
2016-11-29 English
Group of companies' accounts made up to 2016-06-30
Regulatory Filings
2016-11-22 English
Appointment of Non-Executive Director
Board/Management Information Classification · 99% confidence The document is an official announcement filed via RNS (Regulatory Information Service), indicated by the 'RNS Number' and the concluding statement 'This information is provided by RNS'. The core content announces the 'Board Appointment' of a new Non-Executive Director, Lawson Macartney. This directly corresponds to the definition of Board/Management Information (MANG), which covers 'Announcement of changes in the company's board of directors or senior management'. The document is short and serves as a direct announcement, not a comprehensive report.
2016-11-09 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is clearly identified by the header 'RNS Number : 6679O' and contains a standardized form titled 'TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES'. This form details an acquisition or disposal of voting rights that crosses a specific threshold (5%) by a shareholder (Aberdeen Asset Managers Limited). This type of mandatory disclosure regarding significant changes in share ownership is classified as a Major Shareholding Notification.
2016-11-08 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.